Combination PD-1 and PD-L1 inhibitors for kidney cancer are no more beneficial than PD-1 inhibitor alone

By |2019-11-20T10:02:53+00:0020 Nov 2019|Drug treatments|

A recent phase II clinical trial has shown that combined [...]